[go: up one dir, main page]

AT381302B - Verfahren zur herstellung von neuen glycinamidderivaten - Google Patents

Verfahren zur herstellung von neuen glycinamidderivaten

Info

Publication number
AT381302B
AT381302B AT0154680A AT154680A AT381302B AT 381302 B AT381302 B AT 381302B AT 0154680 A AT0154680 A AT 0154680A AT 154680 A AT154680 A AT 154680A AT 381302 B AT381302 B AT 381302B
Authority
AT
Austria
Prior art keywords
producing new
glycinamide derivatives
glycinamide
derivatives
producing
Prior art date
Application number
AT0154680A
Other languages
English (en)
Other versions
ATA154680A (de
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU81068A external-priority patent/LU81068A1/fr
Priority claimed from LU81069A external-priority patent/LU81069A1/fr
Application filed by Continental Pharma filed Critical Continental Pharma
Priority to AT275084A priority Critical patent/AT391134B/de
Priority to AT275184A priority patent/AT392271B/de
Publication of ATA154680A publication Critical patent/ATA154680A/de
Application granted granted Critical
Publication of AT381302B publication Critical patent/AT381302B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0154680A 1979-03-22 1980-03-21 Verfahren zur herstellung von neuen glycinamidderivaten AT381302B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT275084A AT391134B (de) 1979-03-22 1984-08-28 Verfahren zum herstellen von neuen glycinamidderivaten, deren additionssalzen und deren optischen isomeren
AT275184A AT392271B (de) 1979-03-22 1984-08-28 Verfahren zum herstellen von neuen glycinamidderivaten, deren additionssalzen und deren optischen isomeren

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU81068A LU81068A1 (fr) 1979-03-22 1979-03-22 Derives de la glycinamide, leur preparation et utilisation, ainsi que compositions contenant ces derives
LU81069A LU81069A1 (fr) 1979-03-22 1979-03-22 Derive de glycinamide, preparation de ce derive, son utilisation ainsi que composition contenant ce derive

Publications (2)

Publication Number Publication Date
ATA154680A ATA154680A (de) 1986-02-15
AT381302B true AT381302B (de) 1986-09-25

Family

ID=26640253

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0154680A AT381302B (de) 1979-03-22 1980-03-21 Verfahren zur herstellung von neuen glycinamidderivaten

Country Status (18)

Country Link
US (1) US4639468A (de)
AT (1) AT381302B (de)
AU (1) AU536499B2 (de)
CA (1) CA1184567A (de)
CH (1) CH645091A5 (de)
DE (2) DE3010599A1 (de)
DK (1) DK162714C (de)
ES (1) ES8104790A1 (de)
FI (1) FI82033C (de)
FR (1) FR2451913A1 (de)
GB (1) GB2048852B (de)
GR (1) GR68005B (de)
IE (1) IE49751B1 (de)
IL (1) IL59679A (de)
NL (1) NL191508C (de)
NO (1) NO157817C (de)
PT (1) PT70992A (de)
SE (1) SE453917B (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2937698A1 (de) * 1979-09-18 1981-04-02 A. Nattermann & Cie GmbH, 5000 Köln N-propionylsarcosinanilide, deren herstellungsverfahren und arzneimittel auf deren basis
FI832935A (fi) * 1982-08-20 1984-02-21 Midit Derivat av w-aminosyror, deras framstaellning samt dessa derivat innehaollande blandningar
US4798687A (en) * 1987-02-06 1989-01-17 Pennwalt Corporation 2-Amino-N-[1,2-Diphenyl-1-(thifluoromethyl)ethyl]acetamide derivatives
US4904681A (en) * 1987-12-01 1990-02-27 G. D. Searle & Co. D-cycloserine and its prodrugs as cognitive enhancers
US4891058A (en) * 1988-07-18 1990-01-02 Ici Americas Inc. 1-alkyl-3-aryl imidazolidine-2,4-diones and herbicidal use
US5278191A (en) * 1988-08-31 1994-01-11 G. D. Searle & Co. Diphenylmethylaminoacetamide derivatives as anti-convulsants
US5288905A (en) * 1988-10-07 1994-02-22 G. D. Searle & Co. Glycyl urea derivatives as anti-convulsants
US4944796A (en) * 1988-11-14 1990-07-31 Ici Americas Inc. Certain 2-(disubstituted amino) acetanilide herbicides
DE3915755A1 (de) * 1989-05-13 1990-11-29 Bayer Ag Fungizide mittel sowie substituierte aminosaeureamid-derivate und deren herstellung
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US5075337A (en) * 1989-07-26 1991-12-24 G. D. Searle & Co. Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders
US5153226A (en) * 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
DE4102042A1 (de) * 1991-01-24 1992-07-30 Bayer Ag Substituierte aminosaeureamid-derivate deren herstellung und verwendung als fungizide
US5141960A (en) * 1991-06-25 1992-08-25 G. D. Searle & Co. Tricyclic glycinamide derivatives as anti-convulsants
GB9306899D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
GB9306886D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
US5585358A (en) * 1993-07-06 1996-12-17 Yissum Research Development Corporation Of The Hebrew University Of Jerusalem Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
ES2270462T3 (es) * 1996-05-31 2007-04-01 Allelix Neuroscience Inc. Producto farmaceutico para el tratamiento de trastornos neurologicos y neuropsiquiatricos.
US6191165B1 (en) * 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
ATE375975T1 (de) * 1998-03-26 2007-11-15 Univ Saskatchewan Aliphatische aminosäure und aminophosphonsäure, aminonitrile und aminotetrazole als zellulares rettungsmittel
US6984754B1 (en) 1998-03-26 2006-01-10 University Of Saskatchewan Technologies Inc. Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents
AU2985100A (en) * 1999-02-08 2000-08-25 Checkpoint Genetics, Inc. (n)-substituted amino acids, antioxidant pharmaceutical compositions containing same and methods using same
WO2002007677A2 (en) * 2000-07-21 2002-01-31 Teva Pharmaceutical Industries, Ltd. Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
IL154470A0 (en) * 2000-08-17 2003-09-17 Teva Pharma Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
EP1339669B1 (de) * 2000-11-21 2008-06-04 UCB Pharma, S.A. N-alkylierte gaba verbindungen, verfahren zu deren herstellung und deren verwendung als arzneimittel
UA75114C2 (en) 2001-02-16 2006-03-15 Allelix Neuroscience Inc GlyT-1 INHIBITORS
US20030035784A1 (en) * 2001-03-05 2003-02-20 Kao Corporation Hair cosmetic, aminocarboxylic acid amide and method for producing the same
EP1423168B1 (de) 2001-09-03 2006-02-08 Newron Pharmaceuticals S.p.A. Pharmazeutische zusammensetzung mit gabapentin oder deren analog und einem alpha-aminoamid und analgetische verwendung dieser zusammensetzung
EP1438956A1 (de) * 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-Aminoamidderivate die als Antimigränemittel nützlich sind
ME01801B (me) * 2004-09-10 2011-02-28 Newron Pharm Spa UPOTREBA (R)-(HALOBENZILOKSI) BENZILAMINO-PROPANAMIDA KAO SELEKTIVNIH MODULATORA NATRIJUMOVIH l/ILI KALCIJUMOVIH KANALA
WO2006029966A1 (en) * 2004-09-13 2006-03-23 Ciba Specialty Chemicals Holding Inc. Alkylaminoacetamide lubricant additives
FR2896991A1 (fr) * 2006-02-03 2007-08-10 Inst Nat Sante Rech Med Procede pour preparer un compose organique a l'etat solide et compositions pharmaceutiques comprenant ledit compose organique
CN102351733B (zh) * 2011-07-21 2014-03-19 凯莱英医药化学（阜新）技术有限公司 一种制备2-氨基-n,n-二甲基乙酰胺盐酸盐的方法
IL298516B1 (en) 2014-06-25 2024-11-01 Acuitas Therapeutics Inc Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
JP6053724B2 (ja) * 2014-06-26 2016-12-27 国立大学法人九州大学 イオン交換樹脂及び金属の吸着分離方法
CN107922364B (zh) 2015-06-29 2021-12-31 爱康泰生治疗公司 用于递送核酸的脂质和脂质纳米颗粒制剂
IL286515B2 (en) 2015-10-28 2024-02-01 Acuitas Therapeutics Inc Novel lipids and nanoparticle formulations of lipids for delivery of nucleic acids
CN106187829B (zh) * 2016-07-29 2017-12-15 万华化学集团股份有限公司 一种制备乙二胺基乙磺酸盐的方法
WO2018191657A1 (en) 2017-04-13 2018-10-18 Acuitas Therapeutics, Inc. Lipids for delivery of active agents
EP4410317A3 (de) 2017-04-28 2024-10-30 Acuitas Therapeutics Inc. Neue carbonyllipide und lipidnanopartikelformulierungen zur freisetzung von nukleinsäuren
EP3668833A1 (de) 2017-08-16 2020-06-24 Acuitas Therapeutics, Inc. Lipide zur verwendung in lipidnanopartikelformulierungen
US11524932B2 (en) 2017-08-17 2022-12-13 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
WO2019036000A1 (en) * 2017-08-17 2019-02-21 Acuitas Therapeutics, Inc. LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS
US11542225B2 (en) 2017-08-17 2023-01-03 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
KR101953366B1 (ko) 2018-12-26 2019-02-28 정종문 침향을 포함하는 기억력 및 인지능력을 향상시키는 기능성 건강식품 및 이의 제조방법
EP3908568B1 (de) 2019-01-11 2024-06-26 Acuitas Therapeutics, Inc. Lipide zur lipidnanopartikelfreisetzung von wirkstoffen
USD926577S1 (en) 2019-09-23 2021-08-03 Verdant Ventures Tamper-resistant lid assembly
US11326923B2 (en) 2019-10-08 2022-05-10 Verdant Ventures Tamper-resistant lid assembly for dispensing a premeasured amount of liquid
US11976019B2 (en) 2020-07-16 2024-05-07 Acuitas Therapeutics, Inc. Cationic lipids for use in lipid nanoparticles
IL313486A (en) 2021-12-16 2024-08-01 Acuitas Therapeutics Inc Lipids for use in lipid nanoparticle formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2368208A (en) * 1940-12-16 1945-01-30 Emulsol Corp Chemical compounds and method of preparing same
US2781385A (en) * 1953-09-21 1957-02-12 Gefgy Chemical Corp Diamidocarboxylic acids and certain salts thereof
LU43649A1 (de) * 1962-05-09 1963-07-16
JPS5319654B2 (de) * 1974-03-14 1978-06-22
DE2832009A1 (de) * 1978-07-20 1980-01-31 Deutsches Krebsforsch Verwendung von sarkosin und sarkosinderivaten ls tumorhemmende wirksubstanzen

Also Published As

Publication number Publication date
AU536499B2 (en) 1984-05-10
FR2451913A1 (fr) 1980-10-17
DK162714B (da) 1991-12-02
SE453917B (sv) 1988-03-14
NL191508B (nl) 1995-04-18
PT70992A (fr) 1980-04-01
NL8001721A (nl) 1980-09-24
IL59679A (en) 1984-11-30
DK162714C (da) 1992-04-21
ES490536A0 (es) 1981-04-16
DK123580A (da) 1980-09-23
IE800599L (en) 1980-09-22
GB2048852B (en) 1983-03-30
NO157817C (no) 1988-05-25
ATA154680A (de) 1986-02-15
NO800830L (no) 1980-09-23
FI82033B (fi) 1990-09-28
SE8002204L (sv) 1980-09-23
US4639468A (en) 1987-01-27
FI82033C (fi) 1991-01-10
AU5678480A (en) 1980-09-25
NL191508C (nl) 1995-08-21
IE49751B1 (en) 1985-12-11
GB2048852A (en) 1980-12-17
GR68005B (de) 1981-10-26
ES8104790A1 (es) 1981-04-16
DE3010599C2 (de) 1989-03-02
FI800900A (fi) 1980-09-23
DE3010599A1 (de) 1980-10-09
CH645091A5 (fr) 1984-09-14
IL59679A0 (en) 1980-06-30
CA1184567A (en) 1985-03-26
DE3050800C2 (de) 1989-06-22
FR2451913B1 (de) 1984-07-13
NO157817B (no) 1988-02-15

Similar Documents

Publication Publication Date Title
AT381302B (de) Verfahren zur herstellung von neuen glycinamidderivaten
ATA10882A (de) Verfahren zur herstellung von neuen 6betahydroxyalkylpenicillansaeurederivaten
AT380259B (de) Verfahren zur herstellung von neuen peptidamiden
AT375078B (de) Verfahren zur herstellung von neuen indolizinderivaten
AT368509B (de) Verfahren zur herstellung von neuen 3-vinylcephalosporinen
AT371816B (de) Verfahren zur herstellung von neuen isocyanurs[urederivaten
AT369375B (de) Verfahren zur herstellung von neuen 3-vinylcephalosporin-derivaten
AT373259B (de) Verfahren zur herstellung von neuen 1oxadethiacephalosporin-derivaten
AT380255B (de) Verfahren zur herstellung von neuen benzo-as-triazin-derivaten
AT373595B (de) Verfahren zur herstellung von neuen chinazolinen
AT368511B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT370725B (de) Verfahren zur herstellung von neuen 16-methoxy-16-methyl-prostaglandin-e1-derivaten
AT374798B (de) Verfahren zur herstellung von neuen aminoisochinolinderivaten
AT372077B (de) Verfahren zur herstellung von neuen benzylidenderivaten
AT372947B (de) Verfahren zur herstellung von neuen trans-6oxodecahydrochinolinen
AT374480B (de) Verfahren zur herstellung von neuen 3-thiovinylcephalosporinderivaten
AT369378B (de) Verfahren zur herstellung von neuen 3-thiovinyl-cephalosporinderivaten
AT374167B (de) Verfahren zur herstellung von neuen naphthacenderivaten
AT374481B (de) Verfahren zur herstellung von neuen 3-thiovinylcephalosporinderivaten
AT375648B (de) Verfahren zur herstellung von neuen carbostyrilderivaten
AT378534B (de) Verfahren zur herstellung von neuen ergopeptinderivaten
ATA246583A (de) Verfahren zur herstellung von neuen carbostyrilderivaten
ATA451583A (de) Verfahren zur herstellung von neuen 1-phenaethylimidazol-derivaten
ATA365181A (de) Verfahren zur herstellung von neuen acylaminobenzoesaeurederivaten
ATA52583A (de) Verfahren zur herstellung von neuen ergopeptinderivaten

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee